AtriCure (ATRC)
AtriCure Current Ratio: 2.802
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ATRC Current Ratio Rankings
| Overall | 70th percentile | 1295 of 4373 |
| Sector | 40th percentile | 300 of 503 in Healthcare |
| Industry | 34th percentile | 42 of 64 in Medical Instruments & Supplies |
ATRC Current Ratio Range, Past 5 Years
| Minimum | 2.056 | Sep 2010 |
| Maximum | 4.546 | Sep 2007 |
| Average | 3.169 |
About Current Ratio
The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. Current assets are cash and any assets expected to be converted into cash within the next year. The ratio illustrates a company's ability to remain solvent.
A current ratio of 1 means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning that it has twice as many current assets as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.
Learn More
You may also be interested in these ATRC related companies
ATRC News
Listen to $ATRC Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3eG8
about 24 days ago by earningscast
about 24 days ago by earningscast
$ATRC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Kwl
about 44 days ago by MarketBrief
about 44 days ago by MarketBrief
Leerink Swann Starts AtriCure Inc. (ATRC) at Outperform; Positive Sales Growth Inflection Point
Mar 20, 7:14AM Street Insider
Mar 20, 7:14AM Street Insider
Listen to $ATRC Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2a3D
about 90 days ago by earningscast
about 90 days ago by earningscast
AtriCure to Announce Fourth Quarter and Full Year 2011 Financial Results
Feb 21, 3:00PM Business Wire
Feb 21, 3:00PM Business Wire
Canaccord Genuity Reiterates a 'Buy' on AtriCure (ATRC); ATRC Has Productive STS
Feb 02, 9:36AM Street Insider
Feb 02, 9:36AM Street Insider
$ATRC Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation
about 163 days ago by Benzinga
about 163 days ago by Benzinga
Listen to $ATRC at piper jaffray health care conference - live at 10:00 AM, ondemand after - http://stks.co/1Jy5
about 179 days ago by earningscast
about 179 days ago by earningscast
$ATRC up 24.2%. Panel Recommends FDA Approval for Atrial Fibrillation Treatment
about 213 days ago by lewisgreen
about 213 days ago by lewisgreen
Great news for cheaper and less invasive treatment from $ATRC : http://on.wsj.com/oMFNyI
about 326 days ago by Mdhemp
about 326 days ago by Mdhemp
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ATRC | 8.99 | +0.58 | +6.90% | 148.16M |
| ATR | 50.61 | -0.45 | -0.88% | 3.366B |
| ATPG | 5.15 | +0.00 | +0.00% | 268.06M |
| ATO | 32.67 | -0.24 | -0.73% | 2.947B |
| ATNI | 32.59 | -0.04 | -0.12% | 503.52M |
| ATML | 7.29 | +0.12 | +1.67% | 3.287B |
| BABY | 11.22 | +0.02 | +0.18% | 330.32M |
| BAB | 29.70 | +0.01 | +0.03% | |
| BAA | 4.37 | +0.16 | +3.80% | 875.27M |
| BA | 70.00 | -1.39 | -1.95% | 52.35B |
